DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer (2016-2020)" report to their offering.
The report provides analysis of the global cancer diagnostics market and the US cancer diagnostics market, with detailed analysis of market size and growth, penetration and market share. The report also provides the analysis of the global and the US cancer market, by prevalence, new cases, deaths, type of cancers, etc.
The report also discusses about the different diagnostic test of lung cancer and breast cancer. The diagnostics test analyzed in the report are: MetaStat (Meta Test) (Breast Cancer Test), OncotypeDX (Breast Cancer Test), OncoCyte (Lung Cancer Test), Veracyte's Test (Lung Cancer Test) and Integrated Diagnostics, Inc. Test (Lung Cancer Test).
Cancer is diagnosed using various tools, which confirm the presence of tumour, and the rate of its growth within the body. Cancer diagnosis can be segmented into: imaging testing, endoscopy, biopsy and tumour marker. Each segment can be sub segmented.
The global cancer diagnostic market is expected to increase at a significant growth rate during the forecasted period (2016-2020). The global cancer diagnostic market is supported by various growth drivers, such as the rising incidence of cancer, sedentary lifestyle, growing technological advancement, increasing awareness, etc.
- Integrated Diagnostics, Inc.
Key Topics Covered:
1. Executive Summary
3. Market Analysis
For more information about this report visit http://www.researchandmarkets.com/research/2vs3n3/global_cancer